Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
04/2002
04/25/2002US20020049329 Novel human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them
04/25/2002US20020049243 Pyrrolidine derivatives
04/25/2002US20020049235 Pyridylpyrrole compounds useful as interleukin-and tnf antagonists
04/25/2002US20020049229 Agents for treating neuropathic pain
04/25/2002US20020049227 Pyrazoles and pyrazolopyrimidines having crf antagonistic activity
04/25/2002US20020049223 Quinoline and naphthyridine carboxylic acid antibacterials
04/25/2002US20020049220 Substituted azoles
04/25/2002US20020049210 Heteroaryl amines as novel acetylcholinesterase inhibitors
04/25/2002US20020049205 Pyrazole antimicrobial agents
04/25/2002US20020049198 Administering to a patient having or at risk of having osteoarthritis, a therapeutically effective amount of an bicyclicaromatic or heteroaromatic compound containing amine and hydroxy groups
04/25/2002US20020049195 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc.
04/25/2002US20020049194 A benzoazepin or benzodiazepin derivatives, shows excellent anti-vasopressin activity, vasopressin agonistic activity and oxytocin antagonistic activity, and are useful as antagonist
04/25/2002US20020049193 Inhibitors of the enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase, or rotamase, enzyme activity.
04/25/2002US20020049135 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
04/25/2002DE10050492A1 New butenolide or pentenolide amide derivatives, useful as kinase inhibitors for treating inflammatory and autoimmune diseases, e.g. rheumatoid arthritis, asthma, Alzheimer's disease or osteoarthritis
04/25/2002DE10050490A1 New butenolide or pentenolide amide derivatives, useful as kinase inhibitors for treating inflammatory and autoimmune diseases, e.g. rheumatoid arthritis, asthma, Alzheimer's disease or osteoarthritis
04/25/2002CA2426271A1 Dihydropyrimidine derivatives as cysteine protease inhibitors
04/25/2002CA2426097A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
04/25/2002CA2424729A1 Estrogen receptor modulators
04/25/2002CA2423933A1 Pharmaceutically active sulfanilide derivatives
04/25/2002CA2423792A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
04/25/2002CA2422717A1 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
04/24/2002EP1199306A1 Biarylurea derivatives
04/24/2002EP1198463A2 Compounds for use in treatment of neurological disorders
04/24/2002EP1198453A2 N-(indolcarbonyl-)piperazin derivatives
04/24/2002CN1346353A Farnesy transferase inhibitors having a pyrrole structure and process for preparation thereof
04/24/2002CN1346350A Compound which inhibiti leukocyte adhesion mediated by VLA-4
04/24/2002CN1346348A Amide compounds and medicinal use thereof
04/24/2002CN1346347A Cyclic amine derivatives and uses thereof
04/24/2002CN1083450C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
04/24/2002CN1083439C 2-amino-4-bicyclomino-1,3,5-triazines as herbicides and plant growth regulators
04/24/2002CN1083438C Substituted dismino-1,3,5-triazine derivatives
04/24/2002CN1083431C Novel heterocyclic compounds
04/23/2002US6376670 Bactericide for grampositive bacteria
04/23/2002US6376527 Pyrazole derivatives-p38 map kinase inhibitors
04/23/2002US6376517 For treating vision loss, preventing vision degeneration, and promoting vision regeneration (?neopsis?)
04/23/2002US6376515 Benzamides and related inhibitors of factor Xa
04/23/2002US6376497 Excellent, wide-spectrum antifungal activities and low toxicity
04/23/2002US6376490 Strong n-methyl-d-asparate receptor antagonists; useful in treating strokes, ischemia, and central nervous system injuries
04/23/2002CA2263353C Arylsulfonylimidazolone derivatives as an antitumor agent
04/23/2002CA2246727C Novel substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
04/23/2002CA2223403C Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n-¬(aminoiminomethyl)phenylalkyl|-azaheterocyclylamide compounds
04/18/2002WO2002030927A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same
04/18/2002WO2002030923A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
04/18/2002WO2002030911A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
04/18/2002WO2002030907A1 Pyrazole derivatives for the treatment of viral diseases
04/18/2002WO2002030900A1 Non-deliquescent salt of 4-hydroxypiperidine derivative
04/18/2002WO2002030897A2 Compositions and methods for regulating the nervous system
04/18/2002WO2002030895A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-η BINDING AGENTS
04/18/2002WO2002030892A1 Butenolide and pentenolide derivatives as kinase inhibitors
04/18/2002WO2002030890A1 Nitrogenous five-membered ring compounds
04/18/2002WO2002030881A1 Sulfonylguanidine
04/18/2002WO2002030353A2 NF-λB INHIBITORS
04/18/2002WO2002008217A3 COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS
04/18/2002WO2002008177A8 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
04/18/2002WO2001087830A3 Substituted thioacetamides
04/18/2002WO2001058893A3 Indol-3-yl derivatives and their use as integrin inhibitors
04/18/2002WO2001026656A3 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors
04/18/2002WO2001026644A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto
04/18/2002US20020045771 Reacting 7-OH-protected baccatin III with 3-tert-butyl-2,2-dimethyl4-phenyloxazolidine-5-carboxylic acid
04/18/2002US20020045753 E.g., (S)-N-(4-(4-((3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2 -yl)-carbonyl)-1-piperazinyl)phenyl)-2-thiophenecarboximidamide , or a salt thereof.
04/18/2002US20020045654 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
04/18/2002US20020045644 2-phenylpyran-4-one derivatives
04/18/2002US20020045629 Sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators
04/18/2002US20020045616 Lactam inhibitors of FXa and method
04/18/2002US20020045613 1-aroyl-piperidinyl benzamidines
04/18/2002US20020044899 Controlled, super-fine grinding so particles react completely during leaching; extraction of copper from copper sulfide ores and concentrates
04/18/2002DE10048716A1 Use of sulfonylguanidine derivatives, mostly new compounds, for treating e.g. pain and neurodegeneration, have affinity for the gabapentin binding site
04/18/2002DE10047116A1 DELTA·1·-Pyrroline DELTA · 1 · -Pyrrolines
04/18/2002CA2459746A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
04/18/2002CA2427499A1 Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-.gamma. binding agents
04/18/2002CA2425416A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same
04/18/2002CA2424802A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
04/18/2002CA2424107A1 Sulfonylguanidines
04/18/2002CA2423515A1 Pyrazole derivatives for the treatment of viral diseases
04/17/2002EP1196413A2 Preparation of 7-substituted benzothiophenes
04/17/2002EP1196411A1 Bradykinin b1 receptor antagonists
04/17/2002EP1196410A1 Respiratory syncytial virus replication inhibitors
04/17/2002EP1196394A1 Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists
04/17/2002EP1196392A1 6-carboxyphenyldihydropyridazinone derivatives and use thereof
04/17/2002EP1196388A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
04/17/2002EP1196384A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
04/17/2002EP1196380A2 Indoles and indazoles for the treatment of migraine
04/17/2002EP0831911B1 Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
04/17/2002CN1345319A Triazole compounds with dopamine-D3-receptor affinity
04/17/2002CN1345318A Triazole compounds with dopamine -D3-receptor affinity
04/17/2002CN1345311A 1-arenesulfonyl-2-aryl-pyrolidine and piperidine derivatives for treatment of CNS disorders
04/17/2002CN1345308A Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors
04/17/2002CN1082959C Substituted benzothienylpiperazines, their use as medicaments and processes for their preparation
04/16/2002USRE37664 Use of derivatives of N-phenl-3,4,5,6-tetrahydrophthalimide for the desiccation and abscission of plant organs
04/16/2002US6372779 Anthracene derivatives with carbamoyl groups, amido groups, urea groups and sulfonamide groups
04/16/2002US6372778 Sulfonamide inhibitors of aspartyl protease
04/16/2002US6372767 Benzanilides as potassium channel openers
04/16/2002US6372764 Pyrrolidine modulators of chemokine receptor activity
04/16/2002US6372759 Antithrombotic agents
04/16/2002US6372758 Sulfamato hydroxamic acid metalloprotease inhibitor
04/16/2002US6372752 Enzyme inhibitors, respiratory system disorders, tuberculosis and mycobacterium bactericides
04/16/2002US6372746 Derivatives of acyl-piperazinyl-pyrimidines, preparation thereof and application as medicaments
04/16/2002CA2218552C Benzimidazole compounds and their use as modulators of the gabaa receptor complex
04/16/2002CA2217601C Benzimidazole compounds and their use as modulators of the gabaa receptor complex